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In today’s adult horse population the most pathogenic and common nematode infection is that of the cyathostomins. In the past these worms were of little concern, next to the highly prevalent and pathogenic Strongylus vulgaris. Due to the introduction of macrocyclic lactones (ivermectin and moxidectin) in the 1980’s and 1990’s, S. vulgaris is no longer considered a big risk in domestic horse populations. Instead the cyathostomins took over and are presently considered the most pathogenic horse nematode. Cyathostomins are prevalent in horse populations around the world. They can cause severe health problems in the horse. Up to 50% of larval cyathostominoses has a fatal ending for the horse despite accurate treatment. Since the introduction of anthelmintic drugs the use has increased greatly. To date, worm control in horses is mostly based on the exclusive and regular use of these drugs. Due to the increasing development of anthelmintic resistance against these drugs this approach has to be considered unsustainable.
This sub research is part of an ongoing research at the Utrecht University. 
The purpose of this research is to determine the composition of cyathostomin populations on horse stables in the Netherlands before and after in vitro exposure to ivermectin. The species of cyathostomins will be differentiated for each stable before and after this exposure to varying concentrations of ivermectin. This might give an indication of reduced sensitivity for ivermectin in certain species. When cyathostomin populations of different stables are compared it will show if there are differences between and/or within cyathostomin species.
We used an rLMIA, a reiterative Larval Migration Inhibition Assay (with two sieves), for in vitro selecting of cyathostomins with a reduced sensitivity to ivermectin. This rLMIA is an experimental method. We used a Reverse Line Blot, to differentiate the species of cyathostominae. 
Results of the 4 cyathostomin populations in this research differed strongly. Differences were found between cyathostomin populations, between cyathostomin species and within species. 





The purpose of this study was to determine the species composition of cyathostomin populations and their species specific sensitivity to ivermectin at horse stables in The Netherlands.

This was investigated by analysing the results of the reiterative Larval Migration Inhibition Assay (rLMIA) and the Reverse Line Blot (RLB). In the rLMIA, larvae migrate over two consecutive sieves at different concentrations of ivermectin. A concentration of 0.24 µg/ml ivermectin was used to simulate the therapeutic concentration in vivo. A higher concentration of 30 µg/ml ivermectin was used, which is the maximal concentration in 1% DMSO. By migrating the larvae over two consecutive sieves you are in vitro selecting larvae with a reduced sensitivity to ivermectin. After migration larvae were isolated and differentiated using a RLB. 
Analysing the results should show if the species composition of the selected larvae population is significantly different from the population at the start of the test.  







Cyathostomins, or small strongyles, are considered to be the most prevalent and pathogenic parasites in today’s adult horse population.  The clinical disease it causes, larval cyathostominosis, has a high mortality rate. There are 50 species of cyathostomins recognised. Cyathostomin infection is seen in horses all around the world in all different climates [2,9,22].

Life cycle
Cyathostomins have a direct lifecycle. They enter the horse as an L3 (infective larval stage), when the horse takes up the worm whilst eating grass. In the horse they mature to the L4 and L5 stage and eventually the mature stage.  The mature stage produces new eggs which are shed by the horse with the faeces. This may take only five to six weeks. The eggs are passed onto the pasture where the development to the L1 stage starts. The rate of development to an L3 infective larva is directly related to the temperature and humidity. In warm weather the development from egg to infective L3 may only take three weeks. Under controlled, constant conditions in vitro, the development may only take 10 days. The L3 stage is well protected by a sheet that surrounds it and enables it to survive freezing temperatures. Surviving larvae will not die until the spring. A pasture may therefore be infectious for a long period of time [20].
Cyathostomins have the ability to arrest the maturation process, this is called inhibition. Inhibited stages are not susceptible to deworming treatment, when the horse is dewormed with ivermectin [2,10,20].
This means these worms can survive for long periods of time inside as well as outside of the horse. The part of the worm population that is not exposed to anthelmintic drugs at the time of deworming is called the refugia.
 
Like other nematodes in horses, large numbers of adult cyathostomins may cause clinical disease in the horse. Symptoms can range from lethargy, sudden weight loss, debilitation, dehydration and severe diarrhoea [2,10].

Larval cyathostominosis
This clinical syndrome is caused by the emergence of large numbers of larvae coming out of inhibition at once. These developed L4 stages usually emerge in late winter or early spring. This can cause severe damage to the intestinal wall, which will lead to diarrhoea and severe colic in the horse. The mortality rate may go up to 50 % [2].
Young horses are most vulnerable, but cyathostomins may also cause clinical disease in adult horses. Also the disease is not limited to late winter and early spring, but can occur at any time in the year. Epidemiological risk factors for a cyathostomin infection are age, season and time since last deworming [2,4,8,9,10].

Diagnosis of larval cyathostominosis
Diagnosis of cyathostominosis can be a challenge. Because of severe diarrhoea, faecestests may be negative for worm eggs. In many cases diagnosis will be made post mortem and thus too late. 
Haematology unfortunately is also not diagnostic. Typically it includes neutrofilia, hypoalbuminaemia. Total plasma protein may be normal as a result of elevated alpha and beta plasma protein concentration. All these findings are consistent with a protein-losing enteropathy. 
A useful finding is a large number of L4 larvae in the faeces, but absence of cyathostomin larvae does not rule out an infection. 
Post mortem the colon and caecum may show signs of inflammation, mucosal hyperaemia, haemorrhage, congestion, ulceration and necrosis. In horses that were chronically infected the only finding may be some oedema and irregularities in the mucosal wall. The larvae themselves can of course also be found in the mucosa [2,10].

Treatment
Treatment of larval cyathostominoses is often unsuccessful with a high fatality rate. 
For mild cases or cases in the early stage of cyathostominosis, anthelmintic treatment may be enough. Moxidectin is first choice, because it is effective against inhibited stages (ranging from 10 to 90 % effectiveness) [19]. Fenbendazol is another anthelmintic drug that is effective against the inhibited stages of cyathostomins. Fenbendazol however, belongs to the benzimidazole type drug. Because of the high prevalence of resistance in cyathostominae against this drug type, fenbendazol can only be used after determining it’s efficacy on a wormpopulation with a FECRT (Faecal Egg Count Reduction Test) [8].
Anti-inflammatory treatment is also important due to the damage done to the intestinal wall. Corticosteroids, such as prednisolone and dexamethasone may be used.
Supportive care may be necessary in severe cases, especially in case of hypoproteinemia. This may include fluid therapy, oncotic support and nutritional support [8,10].

Preventive Control measures
There is no control programme available that can be used in all horse populations under all circumstances. The use of anthelmintics and pasture management should be adapted to the individual horse farms.
To control the infection rate in the horse, anthelmintics might be inevitable, but their use needs to be carefully assessed as there has been found anthelmintic resistance in cyathostominae [7,13,15].
Over the last 20 years the control of cyathostomin infection has relied on the repeated use of anthelmintic drugs. On most horse stables the control of worm infection in the horse population is based on regular anthelmintic treatment only. Because of a worldwide increase in resistance against these drugs, this approach is unsustainable [1].
There are other control measures that can be taken. Horses that are kept on pasture could be moved regularly to clean fields. This would have to be done every two or three weeks in summer. L3 larvae on pasture survive longer in the winter than they do in the summer. Still, a field that has been infected in the summer will not be clean till next spring. If rotation of fields is not possible, the faeces could be removed from the pasture on a regular basis, at least twice a week [20].
Horses kept in stalls or stands generally don’t have to be dewormed, as long as the faeces are removed daily and stalls or stands are thoroughly cleaned once a week [20].
In Sweden this pasture management has been researched. Out of 444 horse farms only 6% regularly removed faeces from the pasture. 10% of the horse farms used a rotation schedule for grazing or mixed grazing with other livestock. Only 1% performed FEC on a regular basis [12].

Anthelmintic resistance
There are three important groups of anthelmintics: benzimidazole derivatives (BZ), tetrahydropyrimidines and macrocyclic lactones (MLs). 
BZ resistance in cyathostominae has been reported world wide and is still increasing. In some countries the prevalence of resistance is 100%. It was first reported only a few years after the introduction of the drugs. The rate of development of resistance against this drug type is high [3,7,14].
Anthelmintic resistance in nematodes is nothing new. It was reported for BZ type drugs as early as the mid sixties, only a few years after the introduction of the drug in 1961 [11]. It was reported first in nematodes of the sheep and second in cyathostomins of the horse. The same happened after the introduction of new classes of anthelmintics, like Pyrantel and ivermectin. In the early 1980’s multi-drug resistant (MDR) worms were first reported [11].
Pyrantel (the only important tetrahydropyrimidin in horse treatment) is not effective against the inhibited stages of the cyathostomins. This drug type was introduced in the 1970’s, but reports of resistant worms have only recently become common. Resistance has been reported in Europe and in the USA but it’s not as widely spread as resistance to benzimidazoles. In the 1990’s Pyrantel salts were marketed in the USA as daily low-dose anthelmintics. It appears that this daily low-dose use of the drug contributed to the increasing development of resistance [1,2,7,14].
Unless sensitivity has been proven by a faecal egg count reduction test, the use of either of these drugs risks an ineffective treatment. On one farm using daily low-dosing of Pyrantel, a 0% reduction in FEC (faecal egg count) was found [14,16].
This leaves the MLs as the only group of anthelmintics for horses. Within this group there are two anthelmintics available, moxidectin and ivermectin. Ivermectin was first introduced in 1981 and moxidectin in the late 1990’s.  In 2002, after more than 20 years of worldwide use of ivermectin, there was still no evidence of a decreased efficacy of this drug [14]. Also there has been shown that ivermectin and moxidectin are highly effective against BZ and Pyrantel resistant cyathostomins. The question remained; when and at what rate will resistance to ML’s develop. Because ivermectin is not effective against the mucosal (inhibited) stages of the cyathostomins, which can easily outnumber the luminal stages, development of resistance may be slower than with moxidectin. Moxidectin has however a higher efficacy and therefore a longer egg reappearance period. Moxidectin should therefore be used less frequently than ivermectin, which may also slow down resistance development [3].
In 2007 a Swedish research found no indication for ivermectin resistance in cyathostomins on Swedish horse farms [6].
However, recently (2008) there has been found a reduced efficacy of ivermectin in horse stables in Brazil. This was shown by a shortening of the Egg reappearance period (ERP) [15]. 
Shortly after, ivermectin resistance was researched in different countries.
On a horse farm in Kentucky they found that the ERP was reduced by 50 % since the introduction of IVM in the 1980’s. This shortening of the ERP should be considered as a sign of developing resistance [13,23].
In Italy they found a reduced efficacy for ivermectin in 2009. In one of the researched horse stables this efficacy was less than 90 %, determined with a FECRT. Moxidectin however was found to have an efficacy of 100 % in all tested stables [5].


The knowledge that resistance can spread rapidly and that there are currently no new anthelmintic drugs available is reason for real concern.
Factors contributing to anthelmintic resistance are: high treatment frequencies, high stocking rates, under dosing and off-label use of anthelmintic drugs. A lack of veterinary consulting can also contribute to the problem. 
Another factor in the rate of resistance development could be the size of the refugia. The refugia is the part of the worm population that is not exposed to anthelmintics at the time of treatment. These are the free living stages on the pasture, the worms in horses that are not treated with the others and the inhibited worms (if treated with ivermectin) in treated horses.  These worms maintain a source of susceptible alleles in the worm population. Maintaining a healthy refugium can slow down the development rate of anthelmintic resistance. This has been proven in experimental studies with sheep and computer modelling [1,11].
Possibly there are climate factors that play a role. A study in Australia suggests that drought could stimulate resistance development, by killing free living stages in the environment. This would decrease the size of the refugia [17,18].

As a first response to the problem of drug resistance in horse nematodes some countries, including The Netherlands, have made anthelmintic drugs available only by prescription. This is supposed to lead to a more sustainable use of this drug class. The veterinarian should be involved in advising about frequencies of deworming, the use of the proper drug class, the dose given to the horse and the amount of horses wormed in a population [1,19].

Drug development
New classes of anthelmintics were found to be very effective against different nematodes in different animal hosts. Among others there are the cyclo-octadepsipeptides, emodepside and the oxindole alkaloid, paraherquamide. But no present information is available on the development of these drugs for horses [1]. 

Determining resistance in worms
Resistance or reduced sensitivity to ivermectin can be determined with a FECRT. 
In our research however we used the reiterative Larval Migration  Inhibition Assay (rLMIA), which is an experimental method that selects the worms least susceptible to ivermectin. This method is further explained in the section ‘Materials and Methods’. 











The stable are from different areas of the Netherlands. They were selected based on several criteria: 
-	Willingness to cooperate 
-	The frequency of deworming treatment; four times annually or more.  
-	Access to pasture
-	Age of the horses; three years or older
-	Time since last anthelmintic treatment. This had to be at least 8 weeks ago if treated with ivermectin and at least 12 weeks ago if last treated with moxidectin. 
-	The size of the population


Description of the four populations:

Hai:
A private stable with approximately 40 adult Dutch Warmblood horses. Horses had year round access to pasture and are dewormed in groups, with a frequency of about four annual treatments. Ivermectin and moxidectin were both used, with the last treatment being ivermectin. The horses’ weight was not measured or estimated; instead a steady dose of one tube per horse was given. One tube was sufficient for a weight of 600 kg. At this stable 13 samples were collected. This population has been sampled in a previous season as well. Results from the previous season can be found under Hai1, results from the current sampling can be found under Hai2.

Kon:
A private/breeding stable with 13 adult Frisians and Dutch Warmblood horses. Access to the pasture was limited to the summer months. Horses are dewormed in age groups four times annually. Adults were dewormed with ivermectin. Dosage was determined by estimation of weight. At this stable 13 samples were collected.

Zar:
A riding school and private stable with a mixture of horse breeds (Dutch Warmblood, Shetlanders, Fjords and Criollo’s). All horses were three years or older and of each horse a sample was collected, with a total of 12 samples. All horses were dewormed five times annually with ivermectin. Dosage was determined with a measuring tape. Horses had daily access to pasture, except during winter months. 

Ver:
A private stable with 34 adult riding horses/ponies. Access to the pasture was limited to the summer months. Horses were all dewormed simultaneously four times annually with either ivermectin or moxidectin. The last treatment was ivermectin based. Dosage was determined by estimation of weight. At this stable a total of 34 samples were collected.  

Other stables
Several other stables were sampled. Some of these stables however had not enough FEC positive animals to continue testing with. Others had enough positive samples with high enough EPG, but did not yield enough larvae at the end of the incubation period to perform an rLMIA.

Faeces sampling, McMaster and incubation. 
Faeces samples were taken at four horse stables mentioned above. The samples were only taken from horses over three years old. The samples were collected as fresh as possible, from the top of the faeces so as to minimalize the ground contamination with non-parasitic worms. 
We performed a FEC of the samples with a modified McMaster method. This was done either on the day of sampling or the next morning, in which case the samples were stored at 4 C over night. 
The positive samples were incubated for at least 10 days at 25 ˚C. They were placed in large and small incubator bowls, with 100 grams in the larger bowls and 20 grams in the smaller bowls. A plastic lid was placed loosely on the bowls during their incubation.
They were then taken out of the incubator and filled to the top of the incubator bowl with tapwater, a lid slightly bigger than the bowl was put on. Bowl and lid were turned after which the overlapping edge of the lid was filled with clear water. The larvae were then given time to migrate to the clear water in the lid over night. The next morning they were drained into Bearmann glasses. From these they were collected in a clear water volume of about 20 ml. They were stored at 4 C. until further use. For McMaster protocol see appendix 1.

rLMIA
All collected samples were viewed under microscope and a larval count was made. In this research we used a two sieve rLMIA.
The larvae were exsheathed with 0.1% hypochlorite the day before performing the rLMIA. Viable larvae were collected in a Baermann glass overnight. 
A known number of exsheathed larvae (xL3’s) were pre-incubated in PBS containing different concentrations of ivermectin. The xL3’s migrated over two sieves at different concentrations of ivermectin: 0 µg/ml (the control), 0.24 µg/ml (therapeutic concentration) and 30 µg/ml (maximal concentration in 1 % DMSO). The test was performed in twofold for more reliable results. 
This test is based on the selection of the least susceptible larvae by repeating the migration in the presence of ivermectin. If the larvae population is homogenous in its susceptibility, all larvae will have an equal chance of migration at any level of ivermectin concentration. Migration percentages should then be comparable for the two consecutive sieves. If however, the population is heterogenous in it’s susceptibility for ivermectin, the proportion of migrating xL3’s will increase with the consecutive sieves. An increasing migration percentage might indicate an in vitro reduced sensitivity to ivermectin in the selected part of the worm population [21For rLMIA protocol see app2. ].

Isolation, lysis and PCR
After migration, larvae that migrated trough the sieves were fixed and stained with iodine and counted per fraction under the microscope. 
Of each fraction (0, 0.24, and 30 IVM µg/ml) 80 larvae were isolated. If there were less than 80 larvae present in a fraction, as many as possible were isolated. This was done under a microscope where every worm was isolated and put in an eppendorf 0.5 ml vial with 2 µl volume. The isolated worms were stored at -80C until further use. 

Worm lysis was then performed on 40 worms per fraction. Lysis was performed with a combination of Worm Lysis Buffer (WLB) and Proteinase A according to the protocol in appendix 3.

The next morning PCR product was made of these 40 worms. Amplifications were made of the InterGenic Spacer region of the xL3’s. To get this specific DNA fragment for species analysing we used forward primer CY26 en reverse primer CY4-biotin.





In this method oligonucleotide probes are attached to a membrane in parallel lines. This membrane is put into the miniblotter perpendicular to the slots which are to be filled with the biotin-labeled PCR products. Hybridization of the single stranded probes with the PCR products is visualized using peroxidase streptavidin and chemiluminescence [9,21].
A 45 slot miniblotter was used to perform a Reverse Line Blot (RLB). The Probes on the membrane used are of the 10 most common cyathostomin species:
Cylicostephanus calicatus, Cyathostomum catinatum, Cylicostephanus goldi, Coronocyclus labratus, Coronocyclus labiatus, Cyathostomum insigne, Cylicocyclus leptostomum, Cylicostephanus longibursatus, Cylicocyclus nassatus, Cyathostomum pateratum. 
These probes are put in the miniblotter perpendicular to the slots that are to be filled with the PCR product of the xL3’s. 
In the first slot as well as the 41st and 42nd a positive control was put in. These positive controls are a mixture of PCR products of xL3’s. The last two slots were filled just with buffer solution. 
After adding the PCR products and the controls to the miniblotter hybridization was accomplished by incubating the miniblotter at 42 C for an hour. The PCR product left after hybridization was then removed by aspiration, after which the membrane was washed according to the protocol.  





We used Microsoft Excel to analyse our data. To calculate the significance of our data we used an online calculating programme called Graphpad Quickcalcs (http://www.graphpad.com/quickcalcs). In this programme we used the two-tailed chi-square test.
Results were only statistically analysed if enough larvae of that particular species were present in all fractions. The minimum being five larvae per fraction per species. For statistical analysis this minimum of 5 xL3’s per species per fraction were required, because all the expected values need to be 5 or higher to enable reliable chi-square calculations. In former seasons of this study a minimum of 7 larvae was used, however this was not achievable in this study so instead the minimum of 5 larvae required for reliable chi-square results were used.  
Differences were considered significant if their P-value was less than 0.05.















Migration of cyathostomin XL3 in rLMIA

XL3 were allowed to migrate in rLMIA and numbers of xL3 that were applied and counted after migration are given in table1.
Migration percentages for sieve 1 and 2 are shown in figure 1. 

In the table and diagram below it shows the entire population of larvae, in other words all species of cyathostominae. First of all it shows that there is a decrease in migration as the concentration of ivermectin increases. A significant increase in migration was found between sieve 1 and sieve 2 at the 30 µg/ml IVM concentration. 

    Migration	 through 2	Sieves with	neg. corr 	     	 	 	After 	After 	
 	XL3’s applied 	 Migration	    mean	Through S1 Applied	 Through	 	neg. Corr.	neg.Corr. Through	After neg. Corr. migration







Table 1. Migration percentages for population Hai1 based on the average amount of larvae applied to the sieve and the counted amount of larvae that migrated through the sieve. 


Figure 1. Migration percentages of xL3’s population Hai1. Migration percentages are shown for sieve 1 and 2 after exposure to the different ivermectin concentrations (0, 0.24 en 30 µg/ml IVM). Results were normalised by setting the migration percentage without ivermectin at 100%. Significant differences are marked in the diagram,    with a P<0.0001.
Stable Hai1

Identification of XL3 by RLB after rLMIA

In this particular population there were three species that seemed to dominate; C. catinatum, C. longibursatus and C. paternatum. Of other species we did not find enough larvae to include them in our analyses.





Table 2 Differentiated xL3’s per sieve.











Migration of cyathostomin XL3 in rLMIA

XL3 were allowed to migrate in rLMIA and numbers of XL3 that were applied and counted after migration are given in table2.
Migration percentages for sieve 1 and 2 are shown in figure 2. 

In the table and diagram below it shows the entire population of larvae, in other words all species of cyathostominae. First of all it shows that there is a decrease in migration as the concentration of ivermectin increases. It shows here that in only one of two 0.24 µg/ml IVM sieves the migration percentage increased from sieve 1 to sieve 2. In the other 0.24 and in both 30 µg/ml IVM sieves the migration percentage decreases. 

    Migration	 through 2	Sieves with	neg. corr 	     	 	 	After 	After 	
 	XL3’s applied 	 Migration	    mean	Through S1 Applied	 Through	 	neg. Corr.	neg.Corr. Through	After neg. Corr. migration




















Identification of XL3 by RLB after rLMIA

In this particular population there were three species that seemed to dominate; C. catinatum, C. longibursatus and C. insigne. Of other species we did not find enough larvae to include them in our analyses. Table 2 shows the actually counted and differentiated larvae per sieve per concentration of ivermectin. Table 3 shows the migration percentages of those species most prevalent in this population.

Table 4. Differentiated xL3’s per sieve.

For C. catinatum we found that at the therapeutic concentration of ivermectin, as well as at the highest soluble concentration, there was a significant decrease in migration percentage. 
For C. longibursatus we found that the migration percentage increases at the therapeutic level of IVM, but decreases at the maximal level of IVM. 
For C. insigne we found that at both concentrations of IVM there is a significant decrease in migration percentage. 


Figure 4. Diagram shows migration percentages for C. Catinatum, C. Insigne and C. Longibursatus. 
(-=0 µg/ml IVM, += 0.24 µg/ml IVM, ++= 30 µg/ml IVM). Results were normalised by setting the migration percentage without ivermectin at 100%. 
   with a P<0.0001.       
   with a P<0.0001 
   with a P<0.004.     








Migration of cyathostomin XL3 in rLMIA

XL3 were allowed to migrate in rLMIA and numbers of XL3 that were applied and counted after migration are given in table 3.
Migration percentages for sieve 1 and 2 are shown in figure 3. 

Below is shown the migration percentages of the whole worm population at the different concentrations of IVM. A decrease is seen as the level of ivermectin increases, just as it did in the population Hai1 and Hai2. An increase is seen at both concentrations from sieve 1 to sieve 2.  
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Identification of XL3 by RLB after rLMIA

After differentiation with the RLB we found that this population contained mainly C. longibursatus, C. catinatum and others (worms we have no probes for on the RLB membrane). XL3 counts are shown in table 4. 


Table 6. Differentiated xL3 per sieve.


For C. catinatum we found that the migration percentages increased from sieve 1 to sieve 2 at both concentrations of IVM. These results were found to be significant only for the highest concentration of IVM, with a P value of less then 0.0001. For the lower concentration, we didn’t find enough C. catinatum per sieve to make a statistically correct analysis. 
For C. longibursatus we also found an increase in migration although this result was only found significant for the higher of the two concentrations used. The P value was less than 0.0005.
For the ‘other’ worms the results were found to be not significant.


Figure 6. . Diagram shows migration percentages for C. Catinatum, C. Insigne and other unidentified cyathostomin species. (-=0 µg/ml IVM, += 0.24 µg/ml IVM, ++= 30 µg/ml IVM). Results were normalised by setting the migration percentage without ivermectin at 100%. Significant differences are marked in the diagram:
     with a P<0.0001.








Migration of cyathostomin XL3 in rLMIA

XL3 were allowed to migrate in rLMIA and numbers of XL3 that were applied and counted after migration are given in table 5.
Migration percentages for sieve 1 and 2 are shown in figure 5. 
Migration	 Through 2	sieves with 	 neg corr	 	 	 	after	after	after
	XL3’s 	 migration	   mean	Through sieve 1	 	 	Neg.corr.	Neg.corr.	Neg.corr.








Table 7. Migration percentages for population Zar based on the average amount of larvae applied to the sieve and the counted amount of larvae that migrated through the sieve.






Figure 7.migration percentages for population Zar. The increased migration at the higher level of ivermectin was found to be statistically significant with a P<0.0110. Significant difference is marked with a      .






Migration of cyathostomin XL3 in rLMIA

XL3 were allowed to migrate in rLMIA and numbers of XL3 that were applied and counted after migration are given in table 6.
Migration percentages for sieve 1 and 2 are shown in figure 6. 

 IVM	 Migration	   Through 2 sieves with	 neg.corr.	 Through	 	 	After neg.	After neg.	After neg.
 Conc.	Applied 	  	mean	S1 applied 	 		Corr. 	Corr.	Corr.







Table 8. Migration percentages for population Ver based on the average amount of larvae applied to the sieve and the counted amount of larvae that migrated through the sieve.

In the diagram below we see that once more migration decreases with an increase of ivermectin concentration. In this population migration percentages did not change from sieve 1 to sieve 2 at either concentration of IVM. ​

​
Figure 8. Migration percentages for population Ver. No significant differences were found between sieves. 







First a conclusion for each horse population will be given separately. Then we will compare the result of each individual stable with one another
. 
Population Hai1
This population shows an increased migration percentage at the 30 µg/ml IVM concentration. This means the wormpopulation of this stable at this time of sampling was heterogenous in its sensitivity to ivermectin. This indicates an in vitro reduced sensitivity in this wormpopulation at this concentration. 
At the therapeutic concentration however there was no difference in percentage between the two sieves. This would indicate that at that concentration the wormpopulation was homogenous in its sensitivity for ivermectin. No indication for in vitro reduced sensitivity was thus found at therapeutic concentrations.
The three most prevalent species at sampling during the first season were C. catinatum, C. paternatum and C. longibursatus. All of these showed an increased migration percentage at the therapeutic level of ivermectin. This would indicate that these three species are heterogenous in their sensitivity for ivermectin and that worms with reduced sensitivity can be selected with rLMIA. 
At the highest concentration of ivermectin only C. longibursatus did not increase in migration percentage. This would indicate that C. longibursatus is homogenous in its sensitivity for ivermectin at this concentration, whilst the other two are heterogenous in their sensitivity for ivermectin at the higher concentration. 

Population Hai2
The decrease in xL3 migration percentage between sieve 1 and 2 at the 30 µg/ml IVM concentration was found to be significant. A decrease in migration percentage is unexpected and will be discussed in the discussion of this report.
The most prevalent cyathostomin species in this population were: C. catinatum, C. insigne and C. longibursatus. For C. catinatum and C. insigne there was a significant decrease in migration percentage. Within these species no in vitro reduced sensitivity for ivermectin was found in this population. For C. longibursatus however, there was a significant increase in migration percentage at the therapeutic level of ivermectin. This indicates a reduced sensitivity for ivermectin of xL3’s in this species at this concentration in this wormpopulation. 
At the higher level of ivermectin however there was a significant decrease in migration. 

Comparison population Hai1 and Hai2. 
The results of population Hai1 and Hai2 differ strongly. 
In the rLMIA the results of Hai1 showed increased migration percentages at the highest level of IVM. Hai2 showed decreased percentages at this level. 
At the therapeutic level both Hai1 and Hai2 showed no significant differences between sieve 1 and sieve 2. This means that at the therapeutic level of ivermectin no indications were found for reduced sensitivity in the cyathostomin worm population at this stable. 
After differentiation with RLB it showed that there was a difference in the three most common species of cyathostomins at this stable. At the first sampling (Hai1) the three most common species were C. catinatum, C. paternatum and C. longibursatus. At the second sampling the three most common species were C. catinatum, C. longibursatus and C. insigne. The samplings were taken about a year apart in the same season. 

Population Koningsland
In this population we see an increase of migration percentage from sieve 1 to sieve 2 at both concentrations of ivermectin, which was in both cases significant. This indicates that the wormpopulation at this stable shows heterogenous sensitivity for ivermectin. C. catinatum and C. longibursatus both showed an increase in migration percentage, with the first being significant at the 0.24 µg/ml concentration of ivermectin and the second at the 30 µg/ml concentration of ivermectin. This indicates an in vitro reduced sensitivity for ivermectin for both those species in this wormpopulation.

Population Zar
For this wormpopulation the only significant result was the slight increase in migration percentage from sieve 1 to sieve 2 at the highest level of ivermectin. This indicates a heterogenous sensitivity for ivermectin at this concentration in this wormpopulation. No further conclusions can be reached because no larvae of this population were differentiated.

Population Ver
No significant differences were found from sieve 1 to sieve 2 in this population. This means the wormpopulation at this horse stable was homogenous in its sensitivity for ivermectin. 

Overall conclusion
Differences were found between cyathostomin species and within cyathostomin species when the populations were compared. 
For C. catinatum there was a significant decrease in migration percentage in the Hai2 population, whereas it showed a significant increase in migration percentage in the Hai1 and Kon population. 
For C. longibursatus there was a significant decrease in migration percentage in the Hai2 population at the 30 µg/ml concentration ivermectin, whereas it showed a significant increase in migration percentage in the Kon population at that concentration.
The overall population of xL3’s in population Hai2 showed to still be sensitive to ivermectin in vitro, while the Kon cyathostomin population shows reduced sensitivity to this drug.
Population Zar showed sensitivity at the therapeutic level, while reduced sensitivity was found at the maximal soluble level of ivermectin. 
All populations differed in their in vitro sensitivity to ivermectin. All four stables dewormed their horse population 4 times a year or more. This means that all the tested worm populations were exposed to anthelmintic drugs on a regular basis. The development of reduced sensitivity to ivermectin might depend strongly on the composition of the worm population. Because only 2 out of 4 stables had xL3’s differentiated no further conclusion can be made based on this study.








To make our result more reliable and statistically significant, all stables should have been sampled twice and researched twice. Also we could have differentiated more worms, which might have led to a more reliable conclusion. It might also give more insight in why the populations differ so strongly in their response to ivermectin.

The results of the larvae harvesting differ strongly per harvest. We also collected the worms still present in the water in the bowl, so worms that did not migrate to the clear water in the lid to collect enough larvae to perform an rLMIA.
We started collecting the worms still present in the bowl, about halfway into the research. However this may have affected the results, for these worms might not migrate very well in the first place.
Possibly the failing of the incubation has to do with something in the faeces. In other words the diet of the horses may affect the ability of the worms to develop into infective L3 larvae. 

In some of the tests the duplo’s were found to differ strongly from one another. This indicates that the rLMIA was not performed properly for that set of duplo’s. rLMIA should therefore be repeated for those populations.  

If the migration percentage decreases, a possible explanation could be that the efficacy of ivermectin depends on the exposure time. For after the second sieve larvae have been exposed for a longer period of time than after the first sieve. 
Technically however a decrease n migration percentage is not possible. This would indicate that the rLMIA was not performed properly. 
Populations that showed a decrease in migration percentage should therefore be retested. In this study this means that the results of population Hai2 are impossible and this population should thus be retested. 
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	Snelweger, die minstens tot 0.1 g nauwkeurig kan afwegen
	Spatel
	Dispensor met verzadigde NaCl oplossing (dichtheid ca 1,17-1,20 g/cm3; 360 g NaCl op 1 l water)
Opm.: Sommigen gebruiken ook wel een verzadigde suikeroplossing. Suiker is erg plakkerig en wordt daarom niet standaard aangeraden. De dichtheid van een verzadigde NaCl suspensie is bovendien bij grazers doorgaans voldoende om de meeste relevante ei-typen te kunnen vinden, met uitzondering van leverboteieren.
	Afsluitbare plastic container van ca 30 ml of vergelijkbaar alternatief
	Mortier met vijzel
	Falconbuis van 50 ml die op tafel gezet kan worden, met schroefdop
	Cylinder of bakje met voldoende doorsnede en inhoud om daarboven een faecessuspensie te zeven 
	Cylindervormige grove zeef (ca 3 mm maaswijdte) of theezeef
	Pasteurse pipet met fiep of ballon
	McMaster telkamer




     1. Weeg 3 gram faeces af in een falconbuis
2.	Doe vanuit dispensor 42 ml verzadigde NaCl in de 50 ml falconbuis.
3.	Zwenk langurig, niet schudden dan komen er erg veel luchtbellen in.
4.	Giet inhoud mortier over zeef in cylinder of bakje. Pers met stamper voorzichtig de vloeistof uit faecesmassa op zeef.
5.	Giet inhoud cylinder of bakje terug in falconbuis.
6.	Sluit falconbuis goed af, zwenk stevig, zodanig dat de buis steeds ondersteboven en weer terug gaat. Eventueel aanwezige eieren worden zo homogeen verdeeld over de gehele inhoud.
7.	Verwijder dop, zuig pasteurse pipet vol uit midden van falconbuis en vul compartiment van de McMaster telkamer. Werk zo snel mogelijk.
8.	Sluit falconbuis opnieuw af, schud opnieuw en vul tweede compartiment.
















L3s van cyathostomen ontscheden in 50x verdunde bleek (onverdunde stock concentratie 5% actieve chloor). Het ontscheden bespoedigen door regelmatig te schudden en ontscheden volgen onder microscoop. Na ongeveer 15 min beginnen ze te ontscheden.  Als > 90% zonder schede is, de XL3’s door Baermann zeef gieten. Het filtraat (dat wat door Baermann zeef is gegaan) door 2e Baermann zeef gieten en XL3s op beide Baermann zeven O/N laten migreren in kraanwater.
Volgende ochtend XL3’s oogsten in ong. 4 ml water, 16 ml PBS toevoegen en laten migreren door 2 cell strainers (40 um) in sambal-bakjes (37 C, in het donker, ong 2 uur). Tijdens migratie evt een keer het bakje ronddraaien (“centrifugeren”) om de XL3s bij de zijkant vandaan te krijgen (daar zitten geen mazen).
De gemigreerde larven oogsten in minstens 3.5 ml.









1+2		30			onverd. (5000-10.000 per ml)

Verunning maken:	20x verd. (0.5 ml onverdunde suspentie +9.5 ml PBS)
			40x verd. (5 ml 20x verd + 5ml PBS) 
2x1 ml van de 40x verdunde oplossing tellen
NB: PIPETEREN VAN xl3 SUSPENTIE ALLEEN ALS DIE GOED GEHOMOGENISEERD IS, ANDERS KLOPT HELE BEREKENING NIET!!!!!!!
Preincubatie in duplo:
4,94 ml PBS + 60 ul DMSO/IVM
1 ml suspentie (onverdund, 1/20 of 1/40)
2h, 37 C in het donker	

Migratie Zeef 1: 
pre-incubatie mengsel door zeef gieten zonder luchtbellen!
1h, 37C in het donker laten migreren
Na afloop gemigreerde XL3 kleuren, tellen en 80 XL3 per fractie isoleren

Migratie Zeef 1+2:
Migratie mengsel dat door zeef 1 is gemigreerd door zeef 2 gieten zonder luchtbellen!
1h, 37C in het donker laten migreren
Na afloop gemigreerde XL3 kleuren, tellen en 80 XL3 per fractie isoleren.

% migratie berekenen en geïsoleerde XL3 in RLB differentiëren.








I2 staining solution: 50 g I2 and 100 g KI in 1L H2O.

Worm Lysis Buffer (WLB), (Kwa et al., J Mol Biol, 1995)
For 10 ml:
All stock solutions are stored in -20 (drawer Mol Biol)

50 mM KCl			500 ul 1M KCl 
10 mM Tris, pH 8.0		100 ul 1M Tris 
2.5 mM MgCl2		1000 ul 25 mM MgCl2 (Fermentas)
0.45% NP-40			45 ul 10% NP-40 
0.45% Tween-20		45 ul 10% Tween-20 
0.01% gelatine		100 ul 1% gelatine 

				1790 ul




Heat the solution slightly to dissolve the gelatine completely and store in 1 ml aliquots in WLB box in -20C




L3’s were exsheated for about 15 min in 50x diluted Bleach (Stock contains 15% hypochlorite, keep at 4 C in the dark). 
XL3’s were collected after Baermann and/or after LMIA and stained with I2 staining solution.
Individual XL3’s were collected in 2 ul of the staining solution and transferred to the bottom of a 0.5 ml vial (Corning). The presence of the XL3 in the vial is microscopically confirmed. 
Stained XL3’s can be stored for at least a week in I2 solution at RT without affecting the yield of template DNA. 
Individual XL3’s are stored at -20 C (-80 C may be better for long term storage). 

Lysis:
25 ul WLB/Prot K is applied to each vial. Do not vortex or mix end over end, because the XL3 has to stay at the bottom of the vial. 
Freeze the sample for at least 15 min at -80 C 
Thaw the sample and spin shortly.
Incubate O/N at 56-60 C.

Next morning: Inactivate prot K in the sample at 95 C for 15 min.
Vortex shortly and spin





(modified from Traversa et al. 2007):
Scheme per reaction	Ul
	
Forw primer CY26 10 uM	0.5












cycle		10 min 94 C
 	 	1 min 94 C
 	 	1 min 55 C	35 x
 	 	2 min 72 	 
 	 	7 min 72 C

Post-PCR processing:
10 ul PCR product is run on 1.5 % agarose gel at 5V per cm gel (50volt >small gel).
(small gel: 50 ml + 3 ul 5 mg/ml EtBr, large gel: 250 ml + 15 ul 5 mg/ml EtBr)






1.	Hybridization with PCR product modified: 6 sept 2010
2.	Dilute PCR products: 10 μl in 150μl 2x SPPE/0.1%DS in 1.5ml tubes
3.	Denature diluted PCR products for 10 min at 100°C in water bath and cool on ice immediately. Centrifuge after samples have cooled down.
4.	Incubate membrane for 5 min in ~10 ml 2 X SSPE/0,1% SDS at room temperature under gentle shaking
5.	Place membrane in miniblotter, with slots perpendicular to line pattern of applied probes.
6.	Remove residual fluid by aspiration.
7.	Fill slots with PCR product (150μl). AVOID AIRBUBBLES. Fill empty slots with 2 x SSPE/0.1% SDS, to avoid cross flow.
8.	Hybridize at hybridization temperature 42°C for 60 min on horizontal surface, no shaking.
9.	Remove samples by aspiration. Remove membrane from blotter
10.	Wash membrane three times in preheated 2 x SSPE/O,5% SDS. First time very short wash, then twice for 10 min at 50°C in water bath under gentle shaking.
11.	Incubate membrane with 20 ml 2x SSPE/0.5% SDS + 5μl streptavidine for 30 min at 42°C in incubator
12.	Wash membrane three times with 2x SSPE/0,5% SDS. First time very short washing, then twice for 10 min at 42°C in incubator. 
13.	Wash membrane twice with 2x SSPE for 5 min at room temperature under gentle shaking
14.	Dispose 2x SSPE
15.	Spread 10ml ECL (5ml ECL1+ 5 ml ECL2, in cold room) over membrane, shake for few minutes so that membrane is fully covered
16.	Cover membrane with overhead sheet
17.	Incubate at room temperature for at least 1 minute
18.	Place membrane between 2 (clean) overhead sheets, remove air bubbles by rolling a tube or some tissue over the sheet, and place them in the exposure cassette
19.	Expose x-ray film for 1-10 min (start with 4 minutes).
20.	Develop film on 5th floor
Membrane stripping
500ml 1% SDS (50ml 10% SDS + 450 ml DI-water) preheated at 90°C
1.	Place membrane in stripping tray, with preheated 1% SDS solution (80°C) and wash twice for 30 min in water bath at 80°C under gentle shaking
2.	Seal membrane in plastic box and store at 4°C.

	Miniblotter 45 (Immunetics, Cambridge, MA 02139)
	Plastic cushions PC 200 (Immunetics)
	Biodyne C Membrane (negatively-charged Nylon 6.6), 0,45μ pore size 60320 (Pall Corporation, Gelman laboratory)
	Streptavidin-POD Conjugate 1 089 153 (500U in 1 ml )(Roche)




	Prepare buffers, do not store longer than 2 days!
1.	300ml 2XSSPE/ 0.1% SDS (30ml 20X SSPE + 3ml 10%SDS + 267ml DI-water)
2.	500ml 2XSSPE/ 0,5% SDS (50ml 20X SSPE + 25ml 10% SDS+ 425ml DI-water)
3.	300ml 2XSSPE (30ml 20X SSPE + 270ml DI-water)
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